Aurelian clinches Polish deal

Companies: AUL   
10/11/2008

Canamens Energy is to pay up to £32.3 million to earn 40 per cent of Aurelian Oil & Gas’s Poznan concessions.

Under the farm-in agreement between the two London-based companies, Canamens, an independent oil and gas concern with backing from Goldman Sachs and others, can earn this stake by meeting 80 per cent of Aurelian’s 90 per cent share of the costs of developing the concessions, including the key Siekerki gas project, up to a maximum €40 million. The deal means that AIM-quoted Aurelian will bear 10 per cent of the work programme expenses and retain a 50 per cent interest in the concessions.

Aurelian’s managing director, Michael Seymour, argues that the farm-out ‘should secure sufficient funding to take this project to the next commercial stage of its development’. Floated two years ago at 55p, Aurelian shares had fallen all the way to 16.5p earlier this month, but have now rallied to 25p, at which level they value the company at £33.9 million, and might fare better than some others in the sector.  

Growth Company Investor subscribers have full access to all our AIM and small-cap share recommendations. To subscribe today with a half-price offer, and gain immediate access to all the recommendations, click here.

Robert Tyerman

Related Articles:
16/05/2008
16/05/2008
15/05/2008
14/05/2008
14/05/2008

AIM£23.73m 17.50p 1.00p
Other company articles:
10/11/2008
02/07/2008
07/04/2008
04/04/2008
08/02/2008

Sponsored Listings

Looking for Great Saving and Investments? Choose from a variety of the UK's favourite saving and investment specialists. Great deals, low rates and all the latest offers.

Looking for Great Saving and Investments? Choose from a variety of the UK's favourite saving and investment specialists. Great deals, low rates and all the latest offers.

Commercial Let Mortgage Looking for Commercial Let Mortgage? Search over 15,000 sites with one click. Your source for everything under the sun.

Recommendations

Advanced Power Components

SPECULATIVE BUY

Uniq

AVOID

Skyepharma

SPECULATIVE BUY

InterQuest

SPECULATIVE BUY

Ark Therapeutics

SPECULATIVE BUY

Enegi Oil

HOLD

Ted Baker

AVOID

Summit Corporation

SPECULATIVE BUY

London Capital Group

BUY

Sinclair (William) Holdings

BUY
AIM